evaxion-biotech.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | AI-Powered Immunotherapies | Evaxion |
| Description | Saving Lives With AI-Powered With our artificial intelligence technology we harness the power of the human immune system to create novel immunotherapies for the patients of today - and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 162.159.129.11 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
evaxion-biotech.com Valuation
|
US$9,568,701
Last updated: 2023-04-27 17:42:29
evaxion-biotech.com has Semrush global rank of 1,106,138. evaxion-biotech.com has an estimated worth of US$ 9,568,701, based on its estimated Ads revenue. evaxion-biotech.com receives approximately 1,104,081 unique visitors each day. Its web server is located in United States, with IP address 162.159.129.11. According to SiteAdvisor, evaxion-biotech.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,568,701 |
| Daily Ads Revenue | US$8,833 |
| Monthly Ads Revenue | US$264,980 |
| Yearly Ads Revenue | US$3,179,753 |
| Daily Unique Visitors | 73,606 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| evaxion-biotech.com. | A | 3599 | IP: 162.159.129.11 |
| evaxion-biotech.com. | A | 3599 | IP: 162.159.130.11 |
| evaxion-biotech.com. | NS | 14400 | NS Record: ns01.one.com. |
| evaxion-biotech.com. | NS | 14400 | NS Record: ns02.one.com. |
| evaxion-biotech.com. | MX | 1198 | MX Record: 0 evaxionbiotech-com01i.mail.protection.outlook.com. |
| evaxion-biotech.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:eu.transmail.net ~all |
| evaxion-biotech.com. | TXT | 86400 | TXT Record: google-site-verification=Unvs1HYjM-ilJw_RlvpsxjpD_SSlIvvmY-XXAt3Q-JM |
| evaxion-biotech.com. | TXT | 3600 | TXT Record: MS=ms80612755 |
HtmlToTextCheckTime:2023-04-27 17:42:29
| Menu About us AI Technology Pipeline Media Investors Careers SEARCH Saving Lives With AI-Powered Immunotherapies Learn more Featured news Evaxion focuses on ERVs for personalized cancer immunotherapy Evaxion has developed a new proprietary AI platform technology ObsERV™ to identify a new source of targets for personalized cancer therapy, potentially enabling treatment of patients that are currently considered unresponsive to cancer immunotherapy. Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients Evaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapy. This potentially enables treatment for patients with cold tumors, normally unresponsive to immunotherapy Evaxion Biotech to announce clinical data for the personalized DNA cancer vaccine EVX-02 at the 2023 American Association for Cancer Research Annual Meeting (AACR) Evaxion announced that the company will |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 00:27:46 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive Location: https://evaxion-biotech.com/ CF-Ray: 6a165cae9e812daa-ORD CF-Cache-Status: HIT Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" X-Content-Type-Options: nosniff Set-Cookie: __cf_bm=awrUh_cVWt2vrwWT6h2QBHOpUmoU9Vw1Mw4vWvYQA.A-1634776066-0-AdAN7RgiIm0BzDkEYW0ZCnHh08hweenE9Pvipxh8QPXdw8uIymZ3FdetRnTvpeS4Elqd0xJaRJe32z4f4xVeias=; path=/; expires=Thu, 21-Oct-21 00:57:46 GMT; domain=.evaxion-biotech.com; HttpOnly; SameSite=None Server: cloudflare HTTP/2 301 date: Thu, 21 Oct 2021 00:27:46 GMT content-type: text/html; charset=utf-8 location: /home/default.aspx cf-ray: 6a165caf38e12b27-ORD cache-control: public, max-age=120, stale-if-error=86400, stale-while-revalidate=86400 strict-transport-security: max-age=3600 cf-cache-status: EXPIRED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" x-content-type-options: nosniff x-xss-protection: 0 set-cookie: __cf_bm=AAggKvR0ORezJ1nBhk6clC73O8N2gY7av_EM3I6mgDQ-1634776066-0-AWCj+meEUhVSGVP3JqfFsUmXK1q8uujVSVvx0QS40hJ/Wam4f1Tc/kfoiRb3HvC95giAgHN+tm3yi4EiMtRa2g4=; path=/; expires=Thu, 21-Oct-21 00:57:46 GMT; domain=.evaxion-biotech.com; HttpOnly; Secure; SameSite=None server: cloudflare HTTP/2 200 date: Thu, 21 Oct 2021 00:27:46 GMT content-type: text/html; charset=utf-8 cf-ray: 6a165cb03a9d2b27-ORD cache-control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 strict-transport-security: max-age=3600 vary: Accept-Encoding cf-cache-status: REVALIDATED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" x-content-type-options: nosniff x-xss-protection: 0 set-cookie: __cf_bm=mNIBROunhziiiBqf2KnQr9UnX_11pLmWEZKK7mEh9y8-1634776066-0-AUK/Zh4/LdFDgJyNFZW/9gY9ef5JXeDgtslzclW0S9B19K9ZwXoskoRtyvofWec/bS3QcoybZK7m/kTkBQOnJlk=; path=/; expires=Thu, 21-Oct-21 00:57:46 GMT; domain=.evaxion-biotech.com; HttpOnly; Secure; SameSite=None server: cloudflare |
evaxion-biotech.com Whois Information
Domain Name: EVAXION-BIOTECH.COM Registry Domain ID: 1661956092_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.one.com Registrar URL: http://www.one.com Updated Date: 2021-05-17T00:12:37Z Creation Date: 2011-06-16T13:48:59Z Registry Expiry Date: 2022-06-16T13:48:59Z Registrar: One.com A/S Registrar IANA ID: 1462 Registrar Abuse Contact Email: abuse@one.com Registrar Abuse Contact Phone: +45 44451220 Domain Status: ok https://icann.org/epp#ok Name Server: NS01.ONE.COM Name Server: NS02.ONE.COM DNSSEC: signedDelegation DNSSEC DS Data: 7460 13 2 81C3D06C45FFA97E0FFDF27E6FE053761A492B72439D7C0A9386DF7FFE8F3C71 >>> Last update of whois database: 2021-09-09T17:08:16Z <<< |